BioCentury
ARTICLE | Company News

Elan, Behrman Capital, Enzon Inc. deal

November 25, 2002 8:00 AM UTC

ELN sold its 80% stake in subsidiary Athena Diagnostics Inc. to Behrman for $82 million in cash. For the first nine months of the year, ELN said it recorded $31.2 million in revenue from Athena. ELN plans to raise $1.5 billion through asset sales as part of its restructuring plan to divest certain assets and focus on neurology, pain management and autoimmune diseases. ...